Skip to Content
Title Body Post datesort icon
VRA moving now

Performance chasing money managers like big short float to make up $$$ at Qtr end.

yesterday,Retail doing well today, 50% short float VRA

should be ready to squueze soon.

03/20/2012 - 10:27

03/21/2012 - 14:32
Retail doing well today, 50% short float VRA

should be ready to squueze soon.

03/20/2012 - 10:27
VFC at July highs

looking for breakout.

09/27/2011 - 11:37
DTLK off $8 to bounce

Easy move back over 9, losses last 2 days off support now, actually a earnings winner and easy to move due to small float.

09/22/2011 - 10:12
HLF coming up to

year highs.

09/20/2011 - 11:44
MAKO chart set up

at highs after 3 down days. 1-2-3 Cooper

09/19/2011 - 12:55
MAKO chart set up

at highs after 3 down days. 1-2-3 Cooper

09/19/2011 - 12:55
ULTA setting up in flag pattern

after excellent earnings last week.

09/16/2011 - 10:01
NFLX misery CSTR gain watch for squeeze today

likely trade opp.

09/15/2011 - 09:46
DTLK nice chart set up

Cheap tech stock with earnings.

09/13/2011 - 09:55
IDCC now, following Nortel patent sale

peer play for IDCC is VHC

07/20/2011 - 10:00
ILMN reversal over 9ema

back to recent highs looks underway.

07/13/2011 - 10:37
Buying another Breakout in PII

working best in dull market.

07/06/2011 - 14:45
Buying another Breakout in PII

working best in dull market.

07/06/2011 - 14:45
Re: VHC- breakout potential

rocking now 37 up 13.5%, be careful if got in on morning note.

07/06/2011 - 12:03
VRUS- another potential breakout

today to watch.

07/06/2011 - 10:24
VHC- breakout potential

new highs

07/06/2011 - 09:41
PLCM nice chart breakout potential

with tech moving well.

06/27/2011 - 10:57
Time to reverse off 1280

on the SP.

06/08/2011 - 10:15
EBS deal is huge

easy 30 dollar stock

10:29AM Emergent BioSolutions announced that the U.S. government has indicated its intention to award it a contract for 44.75 mln doses of BioThrax over a 5 year period (EBS) 22.09 +0.65 : Co announced that the U.S. government has indicated its intention to award Emergent a sole source contract (RFP-2011-N-13414) for the purchase of 44.75 million doses of BioThrax for inclusion in the Strategic National Stockpile (SNS) over a 5 year period. BioThrax is the only vaccine licensed by the FDA to protect against anthrax infection. Emergent anticipates finalizing a contract with the U.S. government during the third quarter of 2011.

05/26/2011 - 11:39